Pharma news

Reset all filters
Geography
Company
Refine search
Bausch & Lomb looks to protect patents in eyedrop lawsuit
Americas
Bausch & Lomb has accused a Nashville-based ophthalmic company of infringing two patents covering its eye-brightening drops, Lumify.   26 October 2021
Eli Lilly can’t avoid royalties in insulin suit
Pharma
Eli Lilly will have to pay undetermined royalties from the net sale of its diabetes treatment to Research Corporation Technologies, an Arizona judge has ruled.   21 October 2021
Big pharma supports Apple health sensor en banc bid
Americas
Apple has secured the backing of a major pharmaceutical industry trade association, as it seeks to persuade the US Court of Appeals for the Federal Circuit to revisit a case centring on a pair of health sensor patents.   19 October 2021
Pharma
A group of 12 Democratic Party members, including Senator Elizabeth Warren, have co-signed a letter calling for the Biden administration to share Moderna’s vaccine technology.   14 October 2021
Pharma
The English High Court has found that a challenged claim of Bayer's targeted cancer drug sorafenib is invalid due to obviousness, in a win for Israeli pharmaceutical company Teva Pharmaceuticals.   11 October 2021
Americas
The unpredictable nature of the US legal landscape has arguably kept IP practitioners on tenterhooks over the past decade.   7 October 2021
Americas
The US Court of Appeals for the Eleventh Circuit has found that the US Food and Drug Administration violated the exclusivity of a patent covering a drug for a rare autoimmune disorder, by approving the same treatment specifically for children.   4 October 2021
Americas
Bristol-Myers Squibb has sued India-based generic maker Alembic over claims that a copycat of the blockbuster leukaemia drug Sprycel, infringes a pair of patents.   4 October 2021
Pharma
A unit of Hong-Kong based Sihuan Pharmaceutical Holdings has filed a lawsuit in Beijing accusing private equity firm CBC Group of stealing trade secrets.   30 September 2021
Pharma
Pharma giant Novartis has filed a patent suit against Crystal Pharmaceuticals after the rival sought to create a generic version of its heart failure drug Entresto.   30 September 2021